TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1098396

Group type: EXPERIMENTAL
Intervention: methyldopa, 750 mg/day
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: spironolactone, 200 mg/day
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: combined treatment with spironolactone and methyldopa
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: spironolactone, 100 mg/day
Number of subjects: 28

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 28
Study: 31969343

Group type: EXPERIMENTAL
Intervention: Tailored Phone Counseling
Number of subjects: 1196

Group type: COMPARATOR
Intervention: Tailored Web intervention
Number of subjects: 1196

Group type: COMPARATOR
Intervention: Tailored Web + Phone intervention
Number of subjects: 1196

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 1196
Study: 30717797

Group type: EXPERIMENTAL
Intervention: Avelumab 10 mg/kg intravenously every 2 weeks (1 L‐mn subgroup)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Avelumab 10 mg/kg intravenously every 2 weeks (2 L subgroup)
Number of subjects: 150
Study: 28911141

Group type: EXPERIMENTAL
Intervention: Intramuscular glucagon administration
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: In vitro glucagon treatment
Number of subjects: 37
Study: 26285330

Group type: EXPERIMENTAL
Intervention: Balneo- and peloid therapy using sulfide-containing siltypeloids
Number of subjects: 186
Study: 23638898

Group type: EXPERIMENTAL
Intervention: Dosage-continued group (n=14)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Step-down group (n=15)
Number of subjects: 54
Study: 21195942

Group type: EXPERIMENTAL
Intervention: Disease management
Number of subjects: 902

Group type: COMPARATOR
Intervention: Traditional care
Number of subjects: 902
Study: 20205017

Group type: EXPERIMENTAL
Intervention: Self-affirmation (affirming a personally important value)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Self-affirmation (affirming a personally unimportant value)
Number of subjects: 84
Study: 17999271

Group type: EXPERIMENTAL
Intervention: Individual cognitive-behaviour therapy (ICBT)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Group cognitive-behaviour therapy (GCBT)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both ICBT and GCBT
Number of subjects: 29
Study: 15467325

Group type: EXPERIMENTAL
Intervention: Cycle ergometer training (TG; n=13; 6 men) - 24 exercise sessions, intensity at 80% of maximal HR, load increase based on dyspnea scores
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (CG; n=12; 6 men) - no intervention
Number of subjects: 25
Study: 11245506

Group type: EXPERIMENTAL
Intervention: Air enriched with 3% CO2 during and for 10 minutes after exercise
Number of subjects: 10

Group type: COMPARATOR
Intervention: Air
Number of subjects: 10
Study: 9926053

Group type: EXPERIMENTAL
Intervention: Community-based services (intensive care)
Number of subjects: 286

Group type: COMPARATOR
Intervention: Community-based services (standard care)
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Community-based services (both intensive and standard care)
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Community-based services (general)
Number of subjects: 286
Study: 7531432

Group type: EXPERIMENTAL
Intervention: MACOP-B
Number of subjects: 497

Group type: COMPARATOR
Intervention: CHOP
Number of subjects: 497
Study: 2923963

Group type: EXPERIMENTAL
Intervention: Cimetidine (1.0 g daily)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ranitidine (1.2 g daily)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control
Number of subjects: 8
Study: 133238

Group type: COMPARATOR
Intervention: Constant torque load offered by an electric motor with perturbations introduced at random during flexion movements.
Number of subjects: 8

Group type: COMPARATOR
Intervention: Increased initial load by a factor of 10.
Number of subjects: 8

Group type: COMPARATOR
Intervention: Relaxed muscle stretching.
Number of subjects: 8

Group type: COMPARATOR
Intervention: Fatigued muscle activation.
Number of subjects: 8
Study: 30921578

Group type: EXPERIMENTAL
Intervention: Active Dynamic Tape
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham Dynamic Tape
Number of subjects: 50
Study: 30530462

Group type: EXPERIMENTAL
Intervention: Mobile app intervention (LowSalt4Life) for 8 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual care (dietary advice) for 8 weeks
Number of subjects: 50
Study: 27075417

Group type: EXPERIMENTAL
Intervention: ENRICH six session face-to-face healthy lifestyle program
Number of subjects: 174

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 174
Study: 25230216

Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 25
Study: 22781020

Group type: EXPERIMENTAL
Intervention: G‐WWB (white wheat bread enriched with guar gum)
Number of subjects: 40

Group type: COMPARATOR
Intervention: WWB (high glycaemic index white wheat bread)
Number of subjects: 40
Study: 20656965

Group type: EXPERIMENTAL
Intervention: Simulator training (15 hours)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Cognitive rehabilitation therapy
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Overall participants
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Current drivers
Number of subjects: 83
Study: 17336254

Group type: EXPERIMENTAL
Intervention: Immunosuppression with antithymocyte globulin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lenalidomide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Azacitidine and decitabine
Number of subjects: 0

Group type: COMPARATOR
Intervention: General therapies for MDS
Number of subjects: 0
Study: 16249542

Group type: EXPERIMENTAL
Intervention: Real-time graphical phone-based feedback for the previous 2 weeks with nurse-initiated support using a web-based graphical analysis of glucose self-monitoring results.
Number of subjects: 93

Group type: COMPARATOR
Intervention: Glucose self-monitoring real-time result transmission and feedback of results for the previous 24 hours.
Number of subjects: 93
Study: 11877349

Group type: EXPERIMENTAL
Intervention: Moderate to severe CHF patients
Number of subjects: 16

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: CHF patients
Number of subjects: 16
Study: 10334256

Group type: EXPERIMENTAL
Intervention: Intranasal 17 beta-oestradiol (S21400) 100 microg, 200 microg, 300 microg, or 400 microg
Number of subjects: 420

Group type: COMPARATOR
Intervention: Oral oestradiol valerate 1 mg or 2 mg
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Intranasal 17 beta-oestradiol (S21400)
Number of subjects: 420
Study: 8726096

Group type: EXPERIMENTAL
Intervention: Large meals
Number of subjects: 7

Group type: COMPARATOR
Intervention: Small meals
Number of subjects: 7
Study: 2249117

Group type: EXPERIMENTAL
Intervention: Flavoxate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6795915

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nitroprusside
Number of subjects: 10
Study: 31328306

Group type: EXPERIMENTAL
Intervention: Dilute apple cider vinegar (0.5% acetic acid)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 22
Study: 28045958

Group type: EXPERIMENTAL
Intervention: rhEGF (50 microg/mL)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study: 26031745

Group type: EXPERIMENTAL
Intervention: Posterior dynamic stabilization (PDS)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Posterior lumbar interbody fusion (PLIF)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Both PDS and PLIF
Number of subjects: 176
Study: 25189743

Group type: EXPERIMENTAL
Intervention: Carrying water
Number of subjects: 16

Group type: COMPARATOR
Intervention: Carrying iron
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Carrying weight (4.4, 8.9, 13.3, 17.8 kg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Base area of container (24 × 24 cm, 35 × 24 cm)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Water occupying 60%-80% of full volume of the container
Number of subjects: 16
Study: 22892731

Group type: EXPERIMENTAL
Intervention: EndoVac irrigation (n = 25)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard needle irrigation (control group, n = 23)
Number of subjects: 48
Study: 20868384

Group type: EXPERIMENTAL
Intervention: Basic fibroblast growth factor (bFGF) spray daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (only skin grafting)
Number of subjects: 40
Study: 17358099

Group type: EXPERIMENTAL
Intervention: esmolol 1.5 mg/kg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: fentanyl 1 microg/kg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: lidocaine 1.5 mg/kg
Number of subjects: 120

Group type: COMPARATOR
Intervention: dextrose 5% 5 mL (control)
Number of subjects: 120
Study: 15848532

Group type: COMPARATOR
Intervention: Group A (stopped steroids)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Group B (continued steroids)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 113
Study: 11981384

Group type: EXPERIMENTAL
Intervention: Active laser treatment (60 mW, transmeatal, once a week for 6 minutes, 4 times over 4 weeks)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo laser treatment (transmeatal, once a week for 6 minutes, 4 times over 4 weeks)
Number of subjects: 45
Study: 9809620

Group type: EXPERIMENTAL
Intervention: Cystic fibrosis lung transplant recipients
Number of subjects: 38
Study: 7696766

Group type: EXPERIMENTAL
Intervention: Hysteroscopic technique A
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hysteroscopic technique B
Number of subjects: 0
Study: 2636655

Group type: COMPARATOR
Intervention: Mildly protein-restricted control diet
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Low protein, low phosphorus diets (three types)
Number of subjects: 95
Study: 7446572

Group type: EXPERIMENTAL
Intervention: Overt rehearsal
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Covert rehearsal
Number of subjects: 300

Group type: COMPARATOR
Intervention: Immediate recall
Number of subjects: 300

Group type: COMPARATOR
Intervention: 20-second unfilled interval
Number of subjects: 300

Group type: COMPARATOR
Intervention: 20-second interval filled with interpolated mental activity
Number of subjects: 300

Group type: COMPARATOR
Intervention: 20-second interval of overt rehearsal
Number of subjects: 300

Group type: COMPARATOR
Intervention: 20-second interval filled with simultaneous overt rehearsal and interpolated mental activity
Number of subjects: 300
Study: 30003519

Group type: EXPERIMENTAL
Intervention: Sit Down and Play (SDP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (handouts regarding developmental milestones)
Number of subjects: 40
Study: 27466719

Group type: EXPERIMENTAL
Intervention: Silicone elastomer (SE) contact lenses
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Rigid gas permeable (GP) contact lenses
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Both lens types
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Keratometric power
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Keratometric astigmatism
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Contact lens-related adverse events
Number of subjects: 57
Study: 25219358

Group type: EXPERIMENTAL
Intervention: Higher CTC telomerase activity (TA) in patients with baseline CTC count ≥5
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Low CTC TA
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: High CTC TA
Number of subjects: 263
Study: 23246896

Group type: EXPERIMENTAL
Intervention: Ultraviolet-C (UVC) irradiation
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo-UVC
Number of subjects: 43
Study: 20561878

Group type: EXPERIMENTAL
Intervention: Aspirin (88.2%‐85.7%)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Statins or cholesterol‐lowering drugs (88.6%‐87%)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Beta-blockers (68%‐55.6%)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Antiarrhythmics
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Angiotensin‐converting enzyme inhibitors
Number of subjects: 232
Study: 19694996

Group type: EXPERIMENTAL
Intervention: PRT-treated PLT concentrates
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (untreated PLTs)
Number of subjects: 66
Study: 19231245

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg intravenously during anesthetic induction)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 15883757

Group type: EXPERIMENTAL
Intervention: Ibutilide (1 mg and 1 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Propafenone (70 mg and 70 mg)
Number of subjects: 40
Study: 11755283

Group type: EXPERIMENTAL
Intervention: Left ventricular ejection fraction (EF)
Number of subjects: 2948

Group type: EXPERIMENTAL
Intervention: End-systolic volume index (ESVI)
Number of subjects: 2948

Group type: EXPERIMENTAL
Intervention: Infarct size (IS)
Number of subjects: 2948

Group type: EXPERIMENTAL
Intervention: Ejection fraction (EF) in overlap group
Number of subjects: 2948

Group type: EXPERIMENTAL
Intervention: Ejection fraction (EF) < 30%
Number of subjects: 2948
Study: 9618751

Group type: EXPERIMENTAL
Intervention: Supraphysiological GH treatment (3 IU/m2)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Physiological GH treatment (1 IU/m2 or 2 IU/m2)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 48
Study: 8580491

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 40
Study: 2728827

Group type: EXPERIMENTAL
Intervention: Intravenous verapamil 0.1 mg.kg‐1
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (thiamylal 5 mg.kg‐1 and succinylcholine 1.5 mg.kg‐1)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Intravenous verapamil 0.1 mg.kg‐1 (hypertensive patients)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (hypertensive patients)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both groups (HR response)
Number of subjects: 44
Study: 848533

Group type: EXPERIMENTAL
Intervention: 25% dextrose
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hartmann's solution
Number of subjects: 60

Group type: COMPARATOR
Intervention: Aminofusin
Number of subjects: 60

Group type: COMPARATOR
Intervention: 10% dextrose
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ritodrine in Hartmann's solution
Number of subjects: 60
Study: 11598599

Group type: EXPERIMENTAL
Intervention: Goggles that reduced visible light by 97%
Number of subjects: 409

Group type: COMPARATOR
Intervention: Control group (no goggles)
Number of subjects: 409
Study: 31060104

Group type: EXPERIMENTAL
Intervention: Violet-almond oil (intranasal, 2 drops three times a day for one month)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Almond oil (intranasal, 2 drops three times a day for one month)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo (1% w/v hydroxypropyl methylcellulose solution, intranasal, 2 drops three times a day for one month)
Number of subjects: 105
Study: 29559167

Group type: EXPERIMENTAL
Intervention: PCV15
Number of subjects: 691

Group type: COMPARATOR
Intervention: PCV13
Number of subjects: 691

Group type: COMPARATOR
Intervention: PPV23
Number of subjects: 691
Study: 27196454

Group type: EXPERIMENTAL
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Laparoscopic Roux-en-Y gastric bypass (LRYGB)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 80
Study: 24672937

Group type: EXPERIMENTAL
Intervention: Leihong Granule (LG) for 3 months
Number of subjects: 80

Group type: COMPARATOR
Intervention: Basic treatment (Control group)
Number of subjects: 80
Study: 22621425

Group type: EXPERIMENTAL
Intervention: Alcohol ingestion
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Alcohol ingestion after pretreatment with sucralfate
Number of subjects: 10

Group type: COMPARATOR
Intervention: Water ingestion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sucralfate ingestion followed by water
Number of subjects: 10
Study: 19823853

Group type: EXPERIMENTAL
Intervention: Closed method (wound closed in two layers over gentamicin impregnated collagen)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Open method (wound left open post-excision)
Number of subjects: 60
Study: 17608873

Group type: EXPERIMENTAL
Intervention: xuezhikang
Number of subjects: 1445

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1445
Study: 15959616

Group type: EXPERIMENTAL
Intervention: Nutritional status and dietary calcium intake
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Body weight and BMI
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Age, menopause, and calcium intake
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Bone area (BA)
Number of subjects: 289
Study: 12392348

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of carbamazepine and lithium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of valproate and olanzapine
Number of subjects: 0
Study: 10434233

Group type: EXPERIMENTAL
Intervention: Oesclim 50
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Oesclim 100
Number of subjects: 24

Group type: COMPARATOR
Intervention: Vivelle 0.05
Number of subjects: 24
Study: 7599237

Group type: EXPERIMENTAL
Intervention: Rocking intervention in addition to ambulation
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (ambulation only)
Number of subjects: 34
Study: 2145702

Group type: EXPERIMENTAL
Intervention: AP-VC-MTX regimen (Doxorubicin, Cisplatin, Vincristine, Cyclophosphamide, Methotrexate)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Doxorubicin/Cyclophosphamide
Number of subjects: 25

Group type: COMPARATOR
Intervention: Doxorubicin/Cisplatin
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Cisplatin
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Doxorubicin
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 4-OOH-Cyclophosphamide
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Vincristine
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX)
Number of subjects: 25
Study: 214866

Group type: EXPERIMENTAL
Intervention: sustained release alprenolol
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 31106922

Group type: EXPERIMENTAL
Intervention: Behavioural skills training (BST)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Generalised training in behavioural interventions (Control)
Number of subjects: 104
Study: 29968684

Group type: EXPERIMENTAL
Intervention: Breathing exercises using panflutes for 30 minutes after meals
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard preoperative education including breathing exercises using incentive spirometers
Number of subjects: 24
Study: 26930535

Group type: EXPERIMENTAL
Intervention: Genetic counseling
Number of subjects: 120

Group type: COMPARATOR
Intervention: Educational booklet
Number of subjects: 120

Group type: COMPARATOR
Intervention: Wait list
Number of subjects: 120
Study: 25323541

Group type: EXPERIMENTAL
Intervention: Gp‐02 (test formulation)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Neupogen™ (reference product)
Number of subjects: 36
Study: 22703536

Group type: EXPERIMENTAL
Intervention: MxA induction assay
Number of subjects: 125

Group type: COMPARATOR
Intervention: CPE assay
Number of subjects: 125
Study: 20303417

Group type: EXPERIMENTAL
Intervention: Rabeprazole (20 mg, twice daily)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 17403087

Group type: EXPERIMENTAL
Intervention: Fondaparinux
Number of subjects: 22418

Group type: COMPARATOR
Intervention: Enoxaparin or unfractionated heparin
Number of subjects: 22418
Study: 15830061

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTX-A)
Number of subjects: 0
Study: 11574336

Group type: EXPERIMENTAL
Intervention: Self-help with 1 cue call and 3 counseling calls (motivational interviewing)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 14

Group type: COMPARATOR
Intervention: Self-help intervention with 1 telephone cue call
Number of subjects: 14
Study: 9780529

Group type: EXPERIMENTAL
Intervention: EORTC-QLQ-C30
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SF-36
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EuroQoL EQ5D (visual analog scale)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Functional Assessment of Cancer Therapy instrument
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Generic and disease-specific instruments
Number of subjects: 0
Study: 8165922

Group type: EXPERIMENTAL
Intervention: Incentive condition
Number of subjects: 109

Group type: COMPARATOR
Intervention: No-incentive condition
Number of subjects: 109
Study: 3047893

Group type: EXPERIMENTAL
Intervention: Tamponade (group SB)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Sclerotherapy (group ST)
Number of subjects: 43
Study: 30672250

Group type: EXPERIMENTAL
Intervention: Preoperative TEAS at sham acupoints combined with postoperative TEAS at Hegu (LI 4) and Neiguan (PC 6)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Preoperative TEAS at Hegu (LI 4) and Neiguan (PC 6) combined with postoperative TEAS at sham acupoints
Number of subjects: 120

Group type: COMPARATOR
Intervention: TEAS at sham acupoints before and after operation
Number of subjects: 120
Study: 28552876

Group type: EXPERIMENTAL
Intervention: Eggshell calcium (300 mg/d)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Calcium carbonate (300 mg/d)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo (no calcium supplementation)
Number of subjects: 54
Study: 26039911

Group type: EXPERIMENTAL
Intervention: Supragingival therapy group (ST, n = 12) received supragingival scaling
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intensive therapy group (IT, n = 12) underwent supra- and subgingival scaling, as well as root planing
Number of subjects: 24

Group type: COMPARATOR
Intervention: Both groups received professional oral hygiene instructions every month
Number of subjects: 24